Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia

Site #102, Brussels

Site #103, Brussels

Site #104, Brussels

Site #101, Ghent

Site #211, Augsburg

Site #202, Berlin

Site #212, Berlin

Site #216, Bochum

Site #210, Dresden

Site #217, Dresden

Site #221, Dresden

Site #203, Düsseldorf

Site #204, Freiburg im Breisgau

Site #206, Hamburg

Site #214, Hamburg

Site #218, Hamburg

Site #213, Hanover

Site #215, Karlsruhe

Site #220, Lübeck

Site #208, Münster

Site #219, Potsdam

Site #209, Schwerin

Site #201, Wuppertal

Site #303, Budapest

Site #309, Budapest

Site #302, Debrecen

Site #308, Sátoraljaújhely

Site #301, Szolnok

Site #307, Szombathely

Site #401, Chelyabinsk

Site #402, Moscow

Site #407, Moscow

Site #411, Moscow

Site #409, Rostov

Site #403, Ryazan

Site #406, Saint Petersburg

Site #408, Saint Petersburg

Site #410, Yaroslavl

Site #503, Alicante

Site #505, Barakaldo

Site #502, Barcelona

Site #507, Córdoba

Site #501, Madrid

Site #504, Madrid

Site #508, Madrid

Site #506, Pamplona